Rolfe Mark 4
4 · FACET BIOTECH CORP · Filed Apr 23, 2010
Insider Transaction Report
Form 4
Rolfe Mark
Sr. Vice Pres. and CSO
Transactions
- Disposition to Issuer
Comon Stock
2010-04-21$27.00/sh−21,333$575,991→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2010-04-21$27.00/sh−64,000$1,728,000→ 0 totalExercise: $10.86Exp: 2016-08-20→ Common Stock (64,000 underlying)
Footnotes (2)
- [F1]These shares were canceled and exchanged for a cash payment of $575,991.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. Includes shares not previously reported that were acquired under a Section 423 employee stock purchase plan
- [F2]This stock option was canceled and exchanged for a cash payment of $1,032,960.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option.